Trial intelligence / Profile preview

Advair HFA vs Advair DISKUS in COPD

NCT00633217Phase 4Completed

Sponsor
GSK
Start
Mar 2008
Primary completion
Feb 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Mar 2008; status: completed.

02

Drugs

fluticasone propionatesalmeterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00633217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00633217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call